Reproducibility of a single-sample method for 99Tcm-MAG3 clearance under clinical conditions

Nuclear Medicine Communications

Volumn 18, Issue 4, 1997, Pages 352-357

  Kotzerke, J ^a   Glatz, S ^a   Grillenberger, K ^a   Kleinschmidt, K ^a   Reske, S N ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MERTIATIDE TC 99M;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CLEARANCE; MAJOR CLINICAL STUDY; MALE; REPRODUCIBILITY;

EID: 0030895815     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006231-199704000-00175     Document Type: Article

References (25)

1. Taylor Jr A, Eshima D, Fritzberg AR, Christian PE, Kasina S. Comparison of iodine-131 OIH and technetium-99m-MAG3 renal imaging in volunteers. J Nucl Med 1986; 27: 795-803.
2. Bubeck B. Technetium-99m-MAG3 im Vergleich zu Jod-Hippuran. Der Nuklearmediziner 1994; 17: 17-27.
3. Piepsz A, Gordon I, Hahn K, Kolinska J, Kotzerke J, Sixt R. Determination of the technetium-99m mercaptoacetyltriglycine plasma clearance in children by means of a single blood sample: A multicentre study. Eur J Nucl Med 1993; 20: 244-248.
4. Meyer G, Kolinska J, Lepej J, Piepsz A, Hahn K. Technetium-99m-mercaptoacetyltriglycine clearance: 'normal' values in children. J Nucl Med 1995; 36: P258.
5. Piepsz A, Tondeur M, Kinthaert J, Ham HR. Reproducibility of technetium-99m mercaptoacetyltriglycine clearance. Eur J Nucl Med 1996; 37: 1883-1890.
6. Blaufox MD, Aurell M, Bubeck B et al. Report of the Radio nuclides in Nephrourology Committee on renal clearance. J Nucl Med 1996; 37: 1883-1890.
7. Bubeck B, Piepenburg R, Grethe U, Ehring B, Hahn K. A new principle to normalize plasma concentrations allowing single-sample clearance determinations in both children and adults. Eur J Nucl Med 1992; 19: 511-516.
8. Kotzerke J. Gemeinsamkeit, Gültigkeit und Grenzen nuklearmedizinischer Clearance-Methoden zur Nierenfunktionsprüfung. Master's Thesis, Hanover, 1991.
9. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; i: 307-310.
10. Klingensmith III WC, Briggs DE, Smith WI. Technetium-99m-MAG3 renal studies: Normal range and reproducibility of physiologic parameters as a function of age and sex. J Nucl Med 1994; 35: 1612-1617.
11. Piepsz A, Tondeur M, Kinthaert J, Ham HR. Can 99mTc-MAG3 be used for clearance measurement? (abstract). Eur J Nucl Med 1995; 22: 814.
12. Florijn KW, Barendregt JNM, Lentjes EGWM et al. Glomerular filtration rate measurement by 'single-shot' injection of inulin. Kidney Int 1994; 46: 252-259.
13. Brøchner-Mortensen J, Rohbrandt K, Lauritzen RB. Precision of single injection [51Cr]EDTA plasma clearance and endogenous creatinine clearance determination in children. Scand J Clin Lab Invest 1977; 37: 625-629.
14. Kotzerke J, Burchert W, Wiese H, von Smekal U, Hundeshagen H. Limitations of clearance determination using the single sample distribution volume method. Eur J Nucl Med 1992; 19: 19-24.
15. Heidenreich P, Oberdorfer M, Hör G. Zuverlässigkeit und methodische Grenzen der globalen und seitengetrennten Nierenclearancebestimmung am teilabgeschirmten Ganzkörper. Nuklearmedizin 1979; 18: 19-25.
16. Leach KG, Slowey HF, Rosen M, Asscher AW. Serial measurement of renal plasma flow. Eur J Nucl Med 1985; 11: 33-35.
17. Sapirstein LA, Vidt DG, Mandel MJ, Hanusek G. Volumes of distribution and clearances of intravenously injected creatinine in dog. Am Physiol 1955; 181: 330-336.
18. Shattuck LA, Eshima D, Taylor Jr AT et al. Evaluation of the hepatobiliary excretion of technetium-99m-MAG3 and reconstitution factors affecting radiochemical purity. J Nucl Med 1994; 35: 349-355.
19. Oberhausen E, Berberich R, Heinrich W. Nuklearmedizinische Bestimmung der Nierenclearance (Methode, Auswertung und Ergebnisse). Electromed (Siemens) 1972; 2: 42-44.
20. Oberhausen E. Grundlagen der Nuklearmedizinischen Nierenclearancebestimmung. In: Pfannenstiel P, ed. Nuklearmedizinische Verfahren bei Erkrankungen der Nieren und ableitenden Harnwege. Konstanz: Schnetztor, 1977: 21-30.
21. Rehling M, Nielsen BV, Pedersen EB, Nielsen LE, Hansen HE, Bacher T. Renal and extrarenal clearance of 99mTc-MAG3: A comparison with 1251-OIH and 51Cr-EDTA in patients representing all levels of glomerular filtration rate. Eur J Nucl Med 1995; 22: 1379-1384.
22. Eshima LA, Eshima D, Hansen L, Algozine CA, Taylor AT. Evaluating the role of protein binding on the renal extraction of technetium-99m tubular agents utilizing an isolated perfused rat kidney model. J Nucl Med 1996; 37: 47P.
23. Early LE, Friedler RM. Changes in renal blood flow and possibly the intrarenal distribution of blood during the natriuresis accompanying saline loading in the dog. J Clin Invest 1965; 44: 929-941.
24. Grady HC, Bullivant EMA. Renal blood flow varies during normal activity in conscious unrestrained rats. Am J Physiol 1992; 262: R926-R932.
25. Schofer O, König G, Bartels U et al. Technetium-99m mercaptoacetyltriglycine clearance: Reference values for infants and children. Eur J Nucl Med 1995; 22: 1278-1281.